Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Oct:206:128-130.
doi: 10.1016/j.thromres.2021.08.019. Epub 2021 Aug 25.

Venous thromboembolism is not a risk factor for the development of bloodstream infections in critically ill COVID-19 patients

Affiliations

Venous thromboembolism is not a risk factor for the development of bloodstream infections in critically ill COVID-19 patients

Wolmet E Haksteen et al. Thromb Res. 2021 Oct.
No abstract available

Keywords: Bloodstream infections; COVID-19; Critically ill; Outcome; Venous thromboembolism.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

References

    1. Cui S., Chen S., Li X., Liu S., Wang F. Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia. J. Thromb. Haemost. Jun 2020;18(6):1421–1424. - PMC - PubMed
    1. Klok F.A., Kruip M.J.H.A., van der Meer N.J.M., Arbous M.S., Gommers D., Kant K.M., et al. Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: an updated analysis. Thromb. Res. Jul 2020;191:148–150. - PMC - PubMed
    1. Giacobbe D.R., Battaglini D., Ball L., Brunetti I., Bruzzone B., Codda G., et al. Bloodstream infections in critically ill patients with COVID-19. Eur. J. Clin. Investig. Oct 2020;50(10) - PMC - PubMed
    1. Cataldo M.A., Tetaj N., Selleri M., Marchioni L., Capone A., Caraffa E., et al. Incidence of bacterial and fungal bloodstream infections in COVID-19 patients in intensive care: an alarming "collateral effect". J. Glob. Antimicrob. Resist. Oct 2020;29(23):290–291. - PMC - PubMed
    1. Dujardin R.W.G., Hilderink B.N., Haksteen W.E., Middeldorp S., Vlaar A.P.J., Thachil J., et al. Biomarkers for the prediction of venous thromboembolism in critically ill COVID-19 patients. Thromb. Res. Dec 2020;196:308–312. - PMC - PubMed